A draft of the second edition of the Good Participatory Practice (GPP) Guidelines for biomedical HIV prevention trials is now available for public comment. The guidelines were first published by Global Advocacy for HIV Prevention (AVAC) and UNAIDS in 2007. Comments will be gathered until Oct. 31, 2010 and can be sent to email@example.com. The finalized guidelines will be released later in 2010.
The draft guidelines can be downloaded online.
The GPP guidelines were created in 2007 to set global standards for stakeholder engagement in biomedical HIV prevention trials. The GPP guidelines are intended to provide trial funders, sponsors and implementers with systematic guidance on how to effectively engage with all stakeholders in the design and conduct of biomedical HIV prevention trials. Other stakeholders such as community members can also use the GPP guidelines to evaluate engagement efforts by trial funders, sponsors and implementers. The GPP guidelines are the first set of global guidelines that address community engagement in biomedical HIV prevention trials.